ReShape Lifesciences Inc. Quarterly Current Ratio in % from Q2 2017 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
ReShape Lifesciences Inc. quarterly Current Ratio history and growth rate from Q2 2017 to Q3 2024.
  • ReShape Lifesciences Inc. Current Ratio for the quarter ending September 30, 2024 was 204 %, a 13.4% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 204 +24.1 +13.4% Sep 30, 2024
Q2 2024 212 +30.5 +16.8% Jun 30, 2024
Q1 2024 223 +42.6 +23.5% Mar 31, 2024
Q4 2023 215 +12 +5.91% Dec 31, 2023
Q3 2023 180 -84.3 -31.9% Sep 30, 2023
Q2 2023 181 -130 -41.8% Jun 30, 2023
Q1 2023 181 +0.82 +0.46% Mar 31, 2023
Q4 2022 203 +32.2 +18.9% Dec 31, 2022
Q3 2022 264 +125 +89.7% Sep 30, 2022
Q2 2022 311 +197 +172% Jun 30, 2022
Q1 2022 180 +37.4 +26.2% Mar 31, 2022
Q4 2021 171 +20 +13.3% Dec 31, 2021
Q3 2021 139 -107 -43.4% Sep 30, 2021
Q2 2021 114 -209 -64.7% Jun 30, 2021
Q1 2021 143 -148 -50.9% Mar 31, 2021
Q4 2020 151 -53 -26% Dec 31, 2020
Q3 2020 246 +71.7 +41.2% Sep 30, 2020
Q2 2020 324 +138 +74.1% Jun 30, 2020
Q1 2020 291 +82.6 +39.7% Mar 31, 2020
Q4 2019 204 -101 -33.1% Dec 31, 2019
Q3 2019 174 -253 -59.2% Sep 30, 2019
Q2 2019 186 -312 -62.6% Jun 30, 2019
Q1 2019 208 -488 -70.1% Mar 31, 2019
Q4 2018 304 -667 -68.7% Dec 31, 2018
Q3 2018 427 -947 -68.9% Sep 30, 2018
Q2 2018 498 -761 -60.5% Jun 30, 2018
Q1 2018 697 Mar 31, 2018
Q4 2017 971 Dec 31, 2017
Q3 2017 1.37K Sep 30, 2017
Q2 2017 1.26K Jun 30, 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.